An FDA committee has given an overwhelming recommendation to new inhaled insulin treatment Afrezza. MannKind Corporation has spent years and many millions of dollars in developing the novel ...

Over the years, researchers have also tried to bring inhaled insulin onto the market. Most attempts have failed, but one called Afrezza is currently available.